Ian A Campbell

Summary

Affiliation: University Hospital of Wales
Country: UK

Publications

  1. ncbi Pulmonary tuberculosis: diagnosis and treatment
    Ian A Campbell
    Llandough Hospital, Cardiff CF64 2XX
    BMJ 332:1194-7. 2006
  2. ncbi Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
    I A Campbell
    Department of Respiratory Medicine, Llandough Hospital, Penarth, Vale of Glamorgan, UK
    Thorax 59:761-8. 2004
  3. ncbi Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
    I A Campbell
    Llandough Hospital, Llandough, Cardiff CF64 2XX
    BMJ 334:674. 2007
  4. ncbi Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial
    I A Campbell
    Chest Department, Llandough Hospital, Penarth, UK
    Scott Med J 54:21-5. 2009
  5. ncbi Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment
    P A Jenkins
    Llandough Hospital, Cardiff, Vale of Glamorgan, UK
    Respir Med 97:439-44. 2003
  6. ncbi Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support
    S Hand
    Chest Department, Llandough Hospital, Cardiff, UK
    Thorax 57:715-8. 2002
  7. ncbi Current medical treatment for tuberculosis. Aspects of chemotherapy and management need clarifying
    Lawrence P Ormerod
    BMJ 326:550; author reply 550. 2003

Collaborators

Detail Information

Publications7

  1. ncbi Pulmonary tuberculosis: diagnosis and treatment
    Ian A Campbell
    Llandough Hospital, Cardiff CF64 2XX
    BMJ 332:1194-7. 2006
  2. ncbi Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
    I A Campbell
    Department of Respiratory Medicine, Llandough Hospital, Penarth, Vale of Glamorgan, UK
    Thorax 59:761-8. 2004
    ..A randomised study was performed to determine whether treatment with cyclical etidronate and/or calcium for 5 years prevents fractures or reverses/reduces bone loss in patients receiving glucocorticoid treatment for asthma...
  3. ncbi Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
    I A Campbell
    Llandough Hospital, Llandough, Cardiff CF64 2XX
    BMJ 334:674. 2007
    ..To determine the optimum duration of oral anticoagulant therapy after an episode of deep vein thrombosis or pulmonary embolism, or both...
  4. ncbi Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial
    I A Campbell
    Chest Department, Llandough Hospital, Penarth, UK
    Scott Med J 54:21-5. 2009
    ..The study was designed to establish the effects of HRT on osteoporosis and fractures over five years in postmenopausal women with asthma receiving regular glucocorticoids and to compare with etidronate...
  5. ncbi Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment
    P A Jenkins
    Llandough Hospital, Cardiff, Vale of Glamorgan, UK
    Respir Med 97:439-44. 2003
    ..Better methods of susceptibility testing and more effective regimens are needed, but it is also evident that improved management of concomitant diseases and better general health will play a major part in increasing survival...
  6. ncbi Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support
    S Hand
    Chest Department, Llandough Hospital, Cardiff, UK
    Thorax 57:715-8. 2002
    ....
  7. ncbi Current medical treatment for tuberculosis. Aspects of chemotherapy and management need clarifying
    Lawrence P Ormerod
    BMJ 326:550; author reply 550. 2003